These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


174 related items for PubMed ID: 6231429

  • 1. 11 beta-Hydroxy-11-ketosteroids equilibrium, a source of misinterpretation in steroid synthesis: evidence through the effects of trilostane on 11 beta-hydroxysteroid dehydrogenase in sheep and human adrenals in vitro.
    Touitou Y, Auzeby A, Bogdan A, Luton JP, Galan P.
    J Steroid Biochem; 1984 Mar; 20(3):763-8. PubMed ID: 6231429
    [Abstract] [Full Text] [Related]

  • 2. 11β-hydroxyandrostenedione, the product of androstenedione metabolism in the adrenal, is metabolized in LNCaP cells by 5α-reductase yielding 11β-hydroxy-5α-androstanedione.
    Swart AC, Schloms L, Storbeck KH, Bloem LM, Toit Td, Quanson JL, Rainey WE, Swart P.
    J Steroid Biochem Mol Biol; 2013 Nov; 138():132-42. PubMed ID: 23685396
    [Abstract] [Full Text] [Related]

  • 3. Cortisol, aldosterone, cortisol precursor, androgen and endogenous ACTH concentrations in dogs with pituitary-dependant hyperadrenocorticism treated with trilostane.
    Sieber-Ruckstuhl NS, Boretti FS, Wenger M, Maser-Gluth C, Reusch CE.
    Domest Anim Endocrinol; 2006 Jul; 31(1):63-75. PubMed ID: 16233969
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Trilostane, an inhibitor of 3β-hydroxysteroid dehydrogenase, has an agonistic activity on androgen receptor in human prostate cancer cells.
    Takizawa I, Nishiyama T, Hara N, Hoshii T, Ishizaki F, Miyashiro Y, Takahashi K.
    Cancer Lett; 2010 Nov 28; 297(2):226-30. PubMed ID: 20831980
    [Abstract] [Full Text] [Related]

  • 6. The antidepressant-like effect of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane involves a regulation of β-type estrogen receptors.
    Espallergues J, Temsamani J, Laruelle C, Urani A, Maurice T.
    Psychopharmacology (Berl); 2011 Mar 28; 214(2):455-63. PubMed ID: 20981412
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Activity of melatonin and other pineal indoles on the in vitro synthesis of cortisol, cortisone, and adrenal androgens.
    Touitou Y, Bogdan A, Auzéby A, Touitou C.
    J Pineal Res; 1989 Mar 28; 6(4):341-50. PubMed ID: 2732894
    [Abstract] [Full Text] [Related]

  • 9. The influence of trilostane on steroid hormone metabolism in canine adrenal glands and corpora lutea-an in vitro study.
    Ouschan C, Lepschy M, Zeugswetter F, Möstl E.
    Vet Res Commun; 2012 Mar 28; 36(1):35-40. PubMed ID: 22113849
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Primary aldosteronism treated by trilostane (3 beta-hydroxysteroid dehydrogenase inhibitor).
    Nakada T, Kazama T, Koike H, Yoshikawa M, Ishikawa S, Katayama T.
    Urology; 1985 Feb 28; 25(2):207-14. PubMed ID: 2982227
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of hydroxysteroid dehydrogenase inhibitors on in-vitro and in-vivo steroidogenesis in the ovine adrenal gland.
    Singh-Asa P, Jenkin G, Thorburn GD.
    J Endocrinol; 1982 Feb 28; 92(2):205-12. PubMed ID: 6278042
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of trilostane in normotensive and hypertensive rats.
    Friemann J, Müller KM.
    Cardiology; 1985 Feb 28; 72 Suppl 1():122-5. PubMed ID: 3863714
    [Abstract] [Full Text] [Related]

  • 17. [Effect of a 3 beta-hydroxysteroid dehydrogenase inhibitor (trilostane) on Cushing's syndrome].
    Nakada T, Ishikawa S, Koike H, Kazama T, Katayama T.
    Nihon Hinyokika Gakkai Zasshi; 1985 Jan 28; 76(1):110-5. PubMed ID: 3859681
    [No Abstract] [Full Text] [Related]

  • 18. Structure-function relationships for the selective inhibition of human 3β-hydroxysteroid dehydrogenase type 1 by a novel androgen analog.
    Pham JH, Will CM, Mack VL, Halbert M, Conner EA, Bucholtz KM, Thomas JL.
    J Steroid Biochem Mol Biol; 2017 Nov 28; 174():257-264. PubMed ID: 29031687
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential inhibition of dehydrogenase and 5-ene----4-ene isomerase activities of purified 3 beta-hydroxysteroid dehydrogenase. Evidence for two distinct sites.
    Luu-The V, Takahashi M, Labrie F.
    J Steroid Biochem Mol Biol; 1991 Nov 28; 40(4-6):545-8. PubMed ID: 1835646
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.